MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABBV — ABBVIE INC.
NYSEABBVIE INC.
$259.93
-1.66(-0.63%)
- O
- 260.51
- H
- 262.32
- L
- 259.00
- V
- 3.77M
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About ABBV
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateDec 10, 2012
Employees57,000
Stock ExchangeNYSE
Ticker SymbolABBV
Websitehttps://www.abbvie.com
Key Financial Statistics
| Market Cap | $467.12B |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $33.33 - $269.39 |
| 52-Week Avg Volume | 7.25M |
| VWAP | $260.24 |
| Transactions | 74,061 |
| Total Recorded Bars | 3,458 days |